Evidence map›Paper›PMID 42226260›Full record

ArticleBMC medicine2026

Association of borderline hypertension defined by ACC-AHA diagnostic criteria during pregnancy with neurodevelopment in infants.

Yuanyuan Zhang, Jiangbo Du, Xue You, Tianyu Sun, Hong Lv, Yangqian Jiang, Tao Jiang, Rui Qin, Xin Xu, Yuanyan Dou and 7 more

Abstract read
In one paragraph

Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yuanyuan Zhang *Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Jiangbo Du *State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Xue You *State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Tianyu SunState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Hong LvState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Yangqian JiangState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Tao JiangDepartment of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Rui QinState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Xin XuState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Yuanyan DouState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Bo XuState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Guangfu JinState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Hongbing ShenState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Zhibin HuState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Yuan LinState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China. yuanlin@njmu.edu.cn.
Xiangqing KongDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China. kongxq@njmu.edu.cn.
Hongxia MaState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, Jiangsu, China. hongxiama@njmu.edu.cn.

Funding

National Key Research and Development Program of China 2021YFC2700600National Key Research and Development Program of China 2021YFC2700705National Key Research and Development Program of China 2024YFC2706900National Natural Science Foundation of China 82003415National Natural Science Foundation of China 82103854National Natural Science Foundation of China 82571940National Natural Science Foundation of China 82574115National Science and Technology Major Project 2024ZD0532103
6 · The paper itself

Abstract

backgroundThe American College of Cardiology (ACC) and the American Heart Association (AHA) revised the diagnostic criteria for hypertension, recommending a lower threshold of 130/80 mmHg for nonpregnant adults. However, this lower threshold has not been adopted in the global obstetrics field. It remains unclear whether applying this new definition to pregnant women would have implications for maternal health and offspring development. The present study aimed to examine potential relationships between maternal borderline hypertension and neurodevelopmental outcomes in infants.

methodsThis study is a secondary analysis conducted within the prospective Jiangsu Birth Cohort in China. A total of 3352 mothers with blood pressure (BP) records and 3641 of their children were included. Pregnant women were categorized as normotensive (systolic BP [SBP] < 130 mmHg and diastolic BP [DBP] < 80 mmHg), borderline hypertensive (SBP 130-139 mmHg and/or DBP 80-89 mmHg), or hypertensive (SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg). Infant neurodevelopment was assessed using the Bayley-III screening test. General linear mixed-effects models and Poisson generalized linear mixed models were applied to evaluate potential associations between maternal borderline hypertension in different trimesters and offspring neurodevelopment, including continuous neurodevelopmental scores and the risk of non-typical development.

resultsCompared with offspring of normotensive mothers, those exposed to maternal borderline hypertension during the first trimester suggested a higher risk of non-typical development in receptive communication (risk ratio [RR], 1.25; 95% confidence interval [CI], 1.00, 1.55; P = 0.045), and exhibited lower expressive communication scores (β, -0.19; [95% CI, -0.38, -0.01]; P = 0.038).When borderline hypertension identified in the first trimester persisted into the second or third trimester, offspring exhibited a more significant reduction in expressive communication scores (β, -0.45; [95% CI, -0.79, -0.11]; P = 0.010).

conclusionsMaternal borderline hypertension, particularly when detected in the first trimester, was associated with lower infant neurodevelopmental scores and a higher risk of non-typical neurodevelopment. The impact appeared more pronounced when borderline hypertension persisted across trimesters. These findings suggest that closer monitoring and management of borderline hypertension during pregnancy may be beneficial for supporting optimal infant neurodevelopment, though further studies are needed to confirm these results.

Indexed as

HypertensionHypertension, Pregnancy-InducedPrenatal Exposure Delayed EffectsAdultBlood PressureChinaFemaleHumansInfantInfant, NewbornMaleNeurodevelopmentPregnancyProspective StudiesBorderline hypertensionHypertensive disorders in pregnancyInfant neurodevelopment

Identifiers

PMID42226260
PMCPMC13440088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.